Search Results for: NVCN
InsideVenture was there for the open at the NYSE Euronext (NYSE: NYX) today, and the company is trying to open up wider markets for venture-backed and late-stage companies to come public. These...
Published:
Last Updated:
NovaBay Pharmaceuticals has filed to come public via an IPO, although this one is being put on the American Stock Exchange instead of NASDAQ or NYSE. It will also trade in Canada on the Toronto...
Published:
NovoCure entered the market sharply below the original anticipated price range and more than 15% before starting to recover.
Published:
Last Updated:
by H.S. AyoubBioHealth Investor.com Biotechnology DENDREON CORP [DNDN] +10.29% NORTHFIELD LABS IN [NFLD] +10.25% COMBINATORX [CRXX] +9.56% ONYX PHARM INC [ONXX] +8.70% SEQUENOM INC [SQNM] +8.08%...
Published:
Here's a list of analyst calls made early Tuesday morning.
Published:
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Published:
Source: ThinkstockNovogen Limited (NASDAQ: NVGN) confirmed Wednesday morning that one of its lead candidate products, TRXE-009, has shown potential to become an important new therapy for both adult...
Published:
Last Updated:
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
Published:
Last Updated:
NovoCure saw its shares skyrocket early on Monday after the firm provided an update for its late-stage cancer trial.
Published:
Last Updated:
NovoCure has made an updated filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
The conventional wisdom says that China has no (or very few) users of social media sites like Facebook Inc. (NASDAQ: FB) and Twitter. But that wisdom may be off the mark.Internet research firm...
Published:
Wedbush has issued a report with some of its best ideas for 2016. These top six ideas from this list have implied upside of at least 50%.
Published:
Last Updated:
NovoCure Ltd. Has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Over the past week, a few biotech companies, such as Cepheid and Valeant Pharmaceuticals, made absolutely massive runs.
Published: